Trial Profile
Efficacy and tolerability of nebivolol compared with carvedilol in patients with coronary artery disease and stage I or II hypertension.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2010
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Carvedilol
- Indications Essential hypertension
- Focus Pharmacodynamics
- Sponsors Forest Laboratories
- 05 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 May 2009 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 29 May 2009 Inclusion criteria amended from NCT.